Table 1: Characteristics of COVID-19 patients with or without hepatitis virus infection.

Variable

Total

(n = 250)

With hepatitis virus infection (n = 61)

without hepatitis virus infection (n = 189)

P value

Male, No. (%)

124(49.6%)

36(59%)

88(46.6%)

0.106

Age, median(IQR)

57.0(47.75~67.0)

54(48~65)

58(47~68)

0.191

Temperature, median (IQR)

36.5(36.3~36.8)

36.5(36.4~37)

36.5(36.3~36.8)

0.306

Heart rate, median (IQR)

82(78~96)

80(73.5~93)

84(80~96)

0.029

Symptoms and signs, No. (%)

 

 

 

 

Fever

104(41.6%)

23(37.7%)

81(42.9%)

0.289

Fatigue

70(28.0%)

19(31.1%)

51(27.0%)

0.317

Headache

12(4.8%)

3(4.9%)

9(4.8%)

0.595

Cough

129(51.6%)

21(34.4%)

108(57.1%)

0.002

Expectoration

32(12.8%)

8(13.1%)

24(12.7%)

0.543

Chest distress/breath shortness

33(13.2%)

8(13.1%)

25(13.2%)

0.587

Diarrhea

15(7%)

4(6.6%)

11(5.8%)

0.281

Nausea and vomiting

10(4.0%)

3(4.9%)

7(3.7%)

0.458

Severity assessment on admission, No. (%)

 

 

 

 

Moderate

192(76.8%)

29(47.5%)

163(86.2%)

 

Serious

46(18.4%)

27(44.3%)

19(10.1%)

 

 

Critical

12(4.8%)

5(8.2%)

7(3.7%)

Treatment, No. (%)

 

 

 

Arbidol

145(60%)

33(54.1%)

112(59.2%)

0.743

Lopinavir/Ritonavir

66(26.4%)

17(27.9%)

49(25.9%)

0.802

Interferon

70(28.0%)

20(32.8%)

50(26.4%)

0.616

Antibiotic

135(54.0%)

41(67.2%)

94(49.7%)

0.027

Traditional Chinese medicine

209(83.6%)

40(65.6%)

169(89.4%)

0.00

Glucocorticoid

53(21.2%)

23(37.7%)

30(15.9%)

0.00

Invasive mechanical ventilation

13(5.2%)

3(4.9%)

10(5.3%)

0.605

Anti-HBV/HCV treatment

 

 

 

 

Entecavir

6(2.4%)

6(9.8%)

0(0%)

 

Abbreviation: COVID-19: Coronavirus Disease 2019; No.: Number; IQR: Interquartile Range.